NCT05287555Completed
Efficacy of Telemetry-assisted Care in Home Home Vented COPD
Randomisiert-kontrollierte Klinische Studie an häuslich Beatmeten COPD-Patienten Zur Überprüfung Der Wirksamkeit Einer Telemetrisch unterstützten Fernbetreuung Durch Das Beatmungszentrum im Vergleich Zur stationären, halbjährlichen Beatmungskontrolle gemäß Leitlinie [Randomized-controlled Clinical Trial in Home Ventilated COPD Patients to Test the Efficacy of Telemetry-assisted Care Compared to Biannual Inpatient Ventilation Control Visits According to the Guideline]
Source: ClinicalTrials.gov · Last updated 2 Dec 2025
Brief summary (registry, in English)
This study in patients suffering of Chronic Obstructive Pulmonary disease (COPD) aims to investigate whether telemonitoring of their non invasive ventilation (NIV) device together with targeted, tailored intervention in case of increasing symptoms or ventilation abnormalities improves the therapy adherence and effectiveness and can reduce the need for hospitalizations.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 54 (actual)
- First submitted
- 24 Feb 2022
- Start date
- 25 Apr 2022
- Primary completion date
- 15 Apr 2025
- Lead sponsor
- Georg Nilius, Prof DR med
- Diseases
- COPD
- NCT number
- NCT05287555
What you commit to
- Study type: Interventional
- Participants enrolled: 54
- From 25 Apr 2022 to the primary completion date, 15 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- contraindication to PAP therapy
- Participation in another study that influences the setting of NIV therapy through specifications regarding device settings or titration
Other
- Absence of signed written informed consent for data protection and study participation.
Who the study is looking for
- NIV-naive / Continuation after 3 Months Interruption
- Indication for initiation of NIV according to S2k guideline of the German Society of Pneumology
- Presence of the signed informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Evang. Kliniken Essen-Mitte gGmbh Coordinator of this site? Confirm its status | Essen | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.